NACDS expects record-setting RxImpact Day

Print Friendly, PDF & Email
ARLINGTON, Va. — The National Association of Chain Drug Stores reports that this year’s RxImpact Day on Capitol Hill will be a record-setter for participation.

NACDS said Wednesday that its ninth annual lobbying drive is expected to include nearly 400 participants, 54% of whom are new recruits. Industry advocates will represent 47 states, 45 colleges and schools of pharmacy, and 33% of all NACDS chain member companies — the highest level to date.

Capitol Building-Senate_featuredTo be March 14 and 15 in Washington, D.C., the 2017 NACDS RxImpact Day on Capitol Hill will bring together NACDS members, pharmacy students and faculty, state pharmacy association representatives and other pharmacy industry advocates to meet with members of Congress and other federal officials.

“With health care front and center again in the national debate, we look forward to offering a vital ‘Access Agenda,’ authentically conveyed by the very people who make pharmacies the trusted face of neighborhood health care,” NACDS president and chief executive officer Steve Anderson said in a statement. “The amazing participation will demonstrate pharmacy’s dedication on the front lines of patient care every day, as well as pharmacy’s commitment to engaging in public policy solutions that work for patients, for collaborators throughout the health care delivery system, and for the nation.”

At last year’s RxImpact Day, pharmacy advocates met with 90% of House of Representatives and Senate offices — a level that NACDS said it expects to sustain this year.

“We look forward to presenting insights about the cost-effective prescription drug benefit in Medicaid and in Medicare, which are important to keep in mind given the current discussions of potential changes to the Affordable Care Act,” Anderson stated. We also will discuss the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592 and S. 109), which would be a positive step forward for improving healthcare access for medically underserved Medicare patients. In addition, advocates will provide their firsthand experiences on other issues that are essential for comprehensive and consistent public policy that are important for pharmacies’ value and viability.”



Comments are closed.